Press Releases NovAccess Global Inc.

Equities

XSNX

US67001N1072

Market Closed - OTC Markets Other stock markets 14:52:21 2024-06-28 EDT			5-day change	1st Jan Change
0.0082 ^USD	-18.00%		-18.00%	-59.20%

05-31	NovAccess Global Inc. announced that it has received $0.009 million in funding	CI
05-21	NovAccess Global Inc. Files Patent with Cedars-Sinai to Advance Its Brain Cancer Fighting Vaccine Platform	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NovAccess Global : Material Agreement Form 8 K	06-04	PU
NovAccess Global : Announces New License to Advance its Immunotherapy Platform	04-30	PU
NovAccess Global Announces $10.7 Million Financing	01-03	AQ
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit	12-01	NE
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform	23-07-28	AQ
NovAccess Global : to Participate in National Brain Tumor Society’s Annual Glioblastoma Awareness Day	23-07-13	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-06-23	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-06-12	AQ
NovAccess Global Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	23-05-12	AQ
NovAccess Global : Lead Scientist Published in High-Profile Medical Journal for Cancer Vaccine Advancements	23-05-11	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-05-02	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-04-18	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K)	23-03-16	AQ
NovAccess Global : Dr. Christopher Wheeler, NovAccess Lead Scientist, Receives Prestigious Golden Axon Award	23-03-15	PU
NovAccess Global to Present at World Orphan Drug Congress	23-02-17	AQ
NOVACCESS GLOBAL INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-02-14	AQ
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-02-13	AQ
NovAccess Global Leadership to Present at World Brain Mapping Foundation Annual Congress	23-02-06	AQ
NovAccess Global : Material Agreement - Form 8-K	23-01-23	PU
NOVACCESS GLOBAL INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	23-01-23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases NovAccess Global Inc.

Equities

XSNX

US67001N1072

Press Releases

Filters